Edwards Lifesciences Corp financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$931.50M $997.90M $1.04B $1.09B $1.24B $1.32B $1.45B $1.68B $1.90B $2.05B $2.32B $2.49B $2.96B $3.44B $3.72B $4.35B $4.39B $5.23B $5.38B $6.00B $0.00M
GM % Gross Margin %
60.26% 62.46% 64.17% 65.34% 66.10% 69.80% 71.78% 70.82% 74.15% 74.74% 73.15% 75.25% 73.09% 74.52% 74.77% 74.37% 75.36% 76.13% 79.96% 77.02% 0.00%
OM Operating Margin
16.58% 17.60% 16.89% 15.82% 16.02% 18.01% 19.65% 17.88% 22.10% 23.10% 21.30% 25.78% 27.65% 29.76% 28.82% 28.48% 30.01% 30.32% 33.29% 28.81% 0.00%
EPS Earnings Per Share
$0.17 $0.17 $0.18 $0.21 $0.25 $0.31 $0.34 $0.45 $0.52 $0.58 $0.76 $0.96 $1.27 $1.57 $1.86 $1.86 $2.22 $2.48 $2.51 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0
Sha. Shares
713.33m 713.56m 694.72m 680.46m 667.95m 678.83m 685.07m 684.45m 692.47m 656.44m 641.85m 647.13m 641.44m 634.86m 627.15m 625.71m 623.25m 624.33m 618.26m 0m 601.3m
OCF Operating Cash Flow
$180.60M $136.80M $232.70M $213.10M $153.20M $165.30M $251.40M $308.20M $362.10M $472.70M $1.02B $549.70M $704.40M $1.00B $926.70M $1.18B $1.05B $1.73B $1.22B $895.80M $0.00M
FCF Free Cash Flow
$138.10M $88.30M $175.20M $156.10M $102.60M $101.30M $189.60M $183.20M $253.10M $364.10M $444.50M $447.00M $528.30M $832.60M $688.10M $925.00M $647.30M $1.41B $973.60M $1.11B $0.00M
FCFS Free Cash Flow Per Share
$0.18 $0.12 $0.25 $0.22 $0.11 $0.15 $0.28 $0.33 $0.36 $0.54 $1.45 $0.69 $0.76 $1.30 $1.09 $1.45 $1.04 $2.25 $1.54 $1.04 $0.00